Table 1.
Day of study | P-value | ||||
---|---|---|---|---|---|
0 | 7 | Interaction | Day | Group | |
Arterial pressure (mmHg) | |||||
Control | 41.6 ± 0.5 | 43.9 ± 0.8 | NS | 0.029 | NS |
IGF-1 | 41.3 ± 3.3 | 42.3 ± 4.3 | |||
Venous pressure (mmHg) | |||||
Control | 2.9 ± 0.6 | 2.7 ± 0.8 | NS 0.061 |
NS | 0.003 |
IGF-1 | 3.3 ± 1.1 | 4.3 ± 1.3 | |||
Heart rate (beats min−1) | |||||
Control | 173 ± 19 | 152 ± 13† | 0.002 | - | - |
IGF-1 | 175 ± 16 | 196 ± 25*† | |||
Circumflex flow (mL min−1) | |||||
Control | 7.6 ± 4.0 | 8.3 ± 3.4 | 0.017 | - | - |
IGF-1 | 5.4 ± 1.4 | 18.9 ± 17.2*† | |||
Circumflex flow (mL min−1 g−1) | |||||
Control | 1.6 ± 0.8 | 1.5 ± 0.7 | 0.008 | - | - |
IGF-1 | 1.0 ± 0.2 | 2.7 ± 1.9*† |
Control n=12; IGF-1-treated n=8. Data analyzed by 2-way repeated measures ANOVA.
Different within-day from Control
within-group from day 0 (P<0.05). Data shown as mean ± SD.